These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide. Sugihara K, Fujimoto S, Motomiya Y, Hashimoto T, Nakamura S, Dohi K. Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091 [Abstract] [Full Text] [Related]
5. Another Marker of Cardiac Dysfunction in Dialysis Patients? Zoccali C. Nephron Clin Pract; 2003 Aug; 93(2):C49-50. PubMed ID: 12616030 [No Abstract] [Full Text] [Related]
6. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Seino Y, Ogata K, Takano T, Ishii J, Hishida H, Morita H, Takeshita H, Takagi Y, Sugiyama H, Tanaka T, Kitaura Y. Am J Med; 2003 Aug 15; 115(3):185-90. PubMed ID: 12935824 [Abstract] [Full Text] [Related]
7. Clinical Significance of Increased Cardiac Troponin T in Patients with Chronic Hemodialysis and Cardiovascular Disease: Comparison to B-Type Natriuretic Peptide and A-Type Natriuretic Peptide Increase. Niizuma S, Iwanaga Y, Washio T, Ashida T, Harasawa S, Miyazaki S, Matsumoto N. Kidney Blood Press Res; 2019 Aug 15; 44(5):1050-1062. PubMed ID: 31487705 [Abstract] [Full Text] [Related]
8. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Am J Nephrol; 2001 Aug 15; 21(2):112-9. PubMed ID: 11359018 [Abstract] [Full Text] [Related]
11. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction]. Uetake S, Takahashi M, Tamano K, Honda T, Kobayashi T, Horinaka S. J Cardiol; 2001 Aug 15; 38(2):61-71. PubMed ID: 11525111 [Abstract] [Full Text] [Related]
14. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Petzold T, Feindt P, Sunderdiek U, Boeken U, Fischer Y, Gams E. Eur J Cardiothorac Surg; 2001 Jun 15; 19(6):859-64. PubMed ID: 11404143 [Abstract] [Full Text] [Related]
17. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Scand J Clin Lab Invest; 2004 Jun 15; 64(7):667-76. PubMed ID: 15513324 [Abstract] [Full Text] [Related]
18. High-Sensitive Cardiac Troponin T for Prediction of Cardiovascular Outcomes in Stable Maintenance Hemodialysis Patients: A 3-Year Prospective Study. Sun L, Wang Y, Zhang N, Xie X, Ding M, Guo H, Li F, Wang X. Kidney Blood Press Res; 2021 Jun 15; 46(4):484-494. PubMed ID: 34167109 [Abstract] [Full Text] [Related]
20. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T. Am J Med; 2002 Dec 15; 113(9):717-22. PubMed ID: 12517360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]